PGD2

Pgd2 is a lipid of Fatty Acyls (FA) class. Pgd2 is associated with abnormalities such as Inflammatory disorder, Pleurisy, Rhinitis, Dehydration and Pneumonia. The involved functions are known as antagonists, fat cell differentiation, Phosphorylation, Process and Gene Expression. Pgd2 often locates in Cell surface, Body tissue, Extracellular, Bone Marrow and Membrane. The associated genes with PGD2 are oxytocin, 1-desamino-(O-Et-Tyr)(2)-, P4HTM gene, PTGS2 gene, PTGDS gene and IL3 gene. The related lipids are 15-deoxyprostaglandin J2, Nonesterified Fatty Acids, Lipopolysaccharides, Steroids and Liposomes. The related experimental models are Knock-out and Rodent Model.

Cross Reference

Introduction

To understand associated biological information of PGD2, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with PGD2?

PGD2 is suspected in Asthma, Dehydration, Allergic rhinitis NOS, Rhinitis, Infertility, Pneumonia and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with PGD2

MeSH term MeSH ID Detail
Arthritis D001168 41 associated lipids
Arrhythmias, Cardiac D001145 42 associated lipids
Leukemia, Experimental D007942 42 associated lipids
Hyperalgesia D006930 42 associated lipids
Leukemia P388 D007941 43 associated lipids
Hypersensitivity, Delayed D006968 43 associated lipids
Coronary Artery Disease D003324 47 associated lipids
Precancerous Conditions D011230 48 associated lipids
Thrombosis D013927 49 associated lipids
Osteosarcoma D012516 50 associated lipids
Per page 10 20 50 100 | Total 189

PubChem Associated disorders and diseases

What pathways are associated with PGD2

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with PGD2?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with PGD2?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with PGD2?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with PGD2?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with PGD2?

Knock-out

Knock-out are used in the study 'Multiple roles of the prostaglandin D2 signaling pathway in reproduction.' (Rossitto M et al., 2015).

Rodent Model

Rodent Model are used in the study 'PKA regulatory IIα subunit is essential for PGD2-mediated resolution of inflammation.' (Kong D et al., 2016).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with PGD2

Download all related citations
Per page 10 20 50 100 | Total 3138
Authors Title Published Journal PubMed Link
Adler DH et al. Inherited human cPLA(2alpha) deficiency is associated with impaired eicosanoid biosynthesis, small intestinal ulceration, and platelet dysfunction. 2008 J. Clin. Invest. pmid:18451993
Poncin S et al. Oxidative stress in the thyroid gland: from harmlessness to hazard depending on the iodine content. 2008 Endocrinology pmid:17884933
Farias SE et al. Formation of eicosanoids, E2/D2 isoprostanes, and docosanoids following decapitation-induced ischemia, measured in high-energy-microwaved rat brain. 2008 J. Lipid Res. pmid:18503030
Wang S et al. AKR1C2 and AKR1C3 mediated prostaglandin D2 metabolism augments the PI3K/Akt proliferative signaling pathway in human prostate cancer cells. 2008 Mol. Cell. Endocrinol. pmid:18508192
Curfs DM et al. Macrophage secretory phospholipase A2 group X enhances anti-inflammatory responses, promotes lipid accumulation, and contributes to aberrant lung pathology. 2008 J. Biol. Chem. pmid:18511424
Qiao L et al. Loss of XIAP sensitizes colon cancer cells to PPARgamma independent antitumor effects of troglitazone and 15-PGJ2. 2008 Cancer Lett. pmid:18477501
Davidson J et al. 7beta-hydroxy-epiandrosterone modulation of 15-deoxy-delta12,14-prostaglandin J2, prostaglandin D2 and prostaglandin E2 production from human mononuclear cells. 2008 J. Steroid Biochem. Mol. Biol. pmid:18996481
Reddy RC et al. Sepsis-induced inhibition of neutrophil chemotaxis is mediated by activation of peroxisome proliferator-activated receptor-{gamma}. 2008 Blood pmid:18535203
Chana RS et al. Statins but not thiazolidinediones attenuate albumin-mediated chemokine production by proximal tubular cells independently of endocytosis. 2008 Am. J. Nephrol. pmid:18535368
Andersen HB et al. Comparison of short term in vitro cultured human mast cells from different progenitors - Peripheral blood-derived progenitors generate highly mature and functional mast cells. 2008 J. Immunol. Methods pmid:18538784
Reyes-Martin P et al. 15-Deoxy-delta12,14-prostaglandin-J(2) up-regulates cyclooxygenase-2 but inhibits prostaglandin-E(2) production through a thiol antioxidant-sensitive mechanism. 2008 Pharmacol. Res. pmid:18456507
Toscano CD et al. NMDA-induced seizure intensity is enhanced in COX-2 deficient mice. 2008 Neurotoxicology pmid:18834901
Royer JF et al. A novel antagonist of prostaglandin D2 blocks the locomotion of eosinophils and basophils. 2008 Eur. J. Clin. Invest. pmid:18837743
Payne CA et al. Loss of prostaglandin D2 synthase: a key molecular event in the transition of a low-grade astrocytoma to an anaplastic astrocytoma. 2008 Mol. Cancer Ther. pmid:18852145
Su RY et al. 15-deoxy-Delta12,14-prostaglandin J2 up-regulates death receptor 5 gene expression in HCT116 cells: involvement of reactive oxygen species and C/EBP homologous transcription factor gene transcription. 2008 Mol. Cancer Ther. pmid:18852146
Oguma T et al. Role of prostaglandin D(2) and its receptors in the pathophysiology of asthma. 2008 Allergol Int pmid:18946232
Nagata D et al. Peroxisome proliferator-activated receptor-gamma and growth inhibition by its ligands in prostate cancer. 2008 Cancer Detect. Prev. pmid:18789607
Yoshimura T et al. Correlation between the prostaglandin D(2)/E(2) ratio in nasal polyps and the recalcitrant pathophysiology of chronic rhinosinusitis associated with bronchial asthma. 2008 Allergol Int pmid:18797183
Zhao W et al. TGF-beta1 attenuates mediator release and de novo Kit expression by human skin mast cells through a Smad-dependent pathway. 2008 J. Immunol. pmid:18981148
Niwa Y et al. Opposite effects of PU.1 on mast cell stimulation. 2008 Biochem. Biophys. Res. Commun. pmid:18680724
Arima M and Fukuda T Prostaglandin D2 receptors DP and CRTH2 in the pathogenesis of asthma. 2008 Curr. Mol. Med. pmid:18691063
Oku H and Umino T Molecular characterization of peroxisome proliferator-activated receptors (PPARs) and their gene expression in the differentiating adipocytes of red sea bream Pagrus major. 2008 Comp. Biochem. Physiol. B, Biochem. Mol. Biol. pmid:18691667
Ryan AJ et al. 15-deoxy-Delta12,14-prostaglandin J2 impairs phosphatidylcholine synthesis and induces nuclear accumulation of thiol-modified cytidylyltransferase. 2008 J. Biol. Chem. pmid:18614529
Ulivi V et al. 15-deoxy-delta 12,14-prostaglandin J(2) inhibits the synthesis of the acute phase protein SIP24 in cartilage: Involvement of COX-2 in resolution of inflammation. 2008 J. Cell. Physiol. pmid:18615580
Gressner OA et al. Pharmacological application of caffeine inhibits TGF-beta-stimulated connective tissue growth factor expression in hepatocytes via PPARgamma and SMAD2/3-dependent pathways. 2008 J. Hepatol. pmid:18486259
Tajima T et al. Lipopolysaccharide induces macrophage migration via prostaglandin D(2) and prostaglandin E(2). 2008 J. Pharmacol. Exp. Ther. pmid:18492946
Ghosh AK et al. Constitutive Smad signaling and Smad-dependent collagen gene expression in mouse embryonic fibroblasts lacking peroxisome proliferator-activated receptor-gamma. 2008 Biochem. Biophys. Res. Commun. pmid:18627765
Genovese T et al. Effect of cyclopentanone prostaglandin 15-deoxy-delta12,14PGJ2 on early functional recovery from experimental spinal cord injury. 2008 Shock pmid:18628687
Alba G et al. Heme oxygenase-1 expression is down-regulated by angiotensin II and under hypertension in human neutrophils. 2008 J. Leukoc. Biol. pmid:18515325
Yoon HJ et al. Regulation of TLR2 expression by prostaglandins in brain glia. 2008 J. Immunol. pmid:18523308
Bissonnette SL et al. An endogenous prostaglandin enhances environmental phthalate-induced apoptosis in bone marrow B cells: activation of distinct but overlapping pathways. 2008 J. Immunol. pmid:18641309
Qiao L et al. Down-regulation of X-linked inhibitor of apoptosis synergistically enhanced peroxisome proliferator-activated receptor gamma ligand-induced growth inhibition in colon cancer. 2008 Mol. Cancer Ther. pmid:18645029
Ragolia L et al. Lipocalin-type prostaglandin D(2) synthase stimulates glucose transport via enhanced GLUT4 translocation. 2008 Prostaglandins Other Lipid Mediat. pmid:18619553
Moreira V et al. Secretory phospholipases A(2) isolated from Bothrops asper and from Crotalus durissus terrificus snake venoms induce distinct mechanisms for biosynthesis of prostaglandins E2 and D2 and expression of cyclooxygenases. 2008 Toxicon pmid:18619987
Capobianco E et al. Effects of natural ligands of PPARgamma on lipid metabolism in placental tissues from healthy and diabetic rats. 2008 Mol. Hum. Reprod. pmid:18621767
Butterfield JH and Weiler CR Prevention of mast cell activation disorder-associated clinical sequelae of excessive prostaglandin D(2) production. 2008 Int. Arch. Allergy Immunol. pmid:18622141
Corren J et al. Clinical and biochemical effects of a combination botanical product (ClearGuard) for allergy: a pilot randomized double-blind placebo-controlled trial. 2008 Nutr J pmid:18625073
Kuehn HS et al. The phosphoinositide 3-kinase-dependent activation of Btk is required for optimal eicosanoid production and generation of reactive oxygen species in antigen-stimulated mast cells. 2008 J. Immunol. pmid:19017959
Chearwae W and Bright JJ PPARgamma agonists inhibit growth and expansion of CD133+ brain tumour stem cells. 2008 Br. J. Cancer pmid:19018263
Lee JH et al. The 15-deoxy-delta 12,14-prostaglandin J2 suppresses monocyte chemoattractant protein-1 expression in IFN-gamma-stimulated astrocytes through induction of MAPK phosphatase-1. 2008 J. Immunol. pmid:19050284
Huang W et al. PPARalpha and PPARgamma effectively protect against HIV-induced inflammatory responses in brain endothelial cells. 2008 J. Neurochem. pmid:18710415
You Q et al. Mechanism of T cell tolerance induction by murine hepatic Kupffer cells. 2008 Hepatology pmid:18712788
Boisvert M et al. PGJ2 antagonizes NF-kappaB-induced HIV-1 LTR activation in colonic epithelial cells. 2008 Virology pmid:18755491
O'Brien JJ et al. 15-deoxy-delta12,14-PGJ2 enhances platelet production from megakaryocytes. 2008 Blood pmid:18755987
Shiraishi Y et al. Cyclooxygenase-2/prostaglandin D2/CRTH2 pathway mediates double-stranded RNA-induced enhancement of allergic airway inflammation. 2008 J. Immunol. pmid:18097056
Napimoga MH et al. Peroxisome proliferator-activated receptor-gamma ligand, 15-deoxy-Delta12,14-prostaglandin J2, reduces neutrophil migration via a nitric oxide pathway. 2008 J. Immunol. pmid:18097063
Horváth B et al. Carbon monoxide-prostaglandin E2 interaction in the hypothalamic circulation. 2008 Neuroreport pmid:18815586
Fujimori K et al. Enhancement of prostaglandin D(2) production through cyclooxygenase-2 and lipocalin-type prostaglandin D synthase by upstream stimulatory factor 1 in human brain-derived TE671 cells under serum starvation. 2008 Gene pmid:18817855
Muñoz U et al. On the mechanism of inhibition of p27 degradation by 15-deoxy-Delta12,14-prostaglandin J2 in lymphoblasts of Alzheimer's disease patients. 2008 Cell. Mol. Life Sci. pmid:18818877
Grill M et al. Effect of endotoxin treatment on the expression and localization of spinal cyclooxygenase, prostaglandin synthases, and PGD2 receptors. 2008 J. Neurochem. pmid:18028337
Song WL et al. Tetranor PGDM, an abundant urinary metabolite reflects biosynthesis of prostaglandin D2 in mice and humans. 2008 J. Biol. Chem. pmid:17993463
Ferreira-Silva V et al. Effects of 15-deoxy-Delta12, 14 prostaglandin J2 and ciglitazone on human cancer cell cycle progression and death: the role of PPARgamma. 2008 Eur. J. Pharmacol. pmid:18054911
Brugger N et al. Pharmacological and functional characterization of novel EP and DP receptor agonists: DP1 receptor mediates penile erection in multiple species. 2008 J Sex Med pmid:18047485
Zhang J et al. Peroxisome proliferator-activated receptor-gamma agonists attenuate angiotensin II-induced collagen type I expression in adventitial fibroblasts. 2008 Clin. Exp. Pharmacol. Physiol. pmid:18047631
Uchida K and Shibata T 15-Deoxy-Delta(12,14)-prostaglandin J2: an electrophilic trigger of cellular responses. 2008 Chem. Res. Toxicol. pmid:18052108
Yu JH et al. SOCS 3 and PPAR-gamma ligands inhibit the expression of IL-6 and TGF-beta1 by regulating JAK2/STAT3 signaling in pancreas. 2008 Int. J. Biochem. Cell Biol. pmid:18035585
Yokoi H et al. Inhibition of FcepsilonRI-dependent mediator release and calcium flux from human mast cells by sialic acid-binding immunoglobulin-like lectin 8 engagement. 2008 J. Allergy Clin. Immunol. pmid:18036650
Kuboki S et al. Peroxisome proliferator-activated receptor-gamma protects against hepatic ischemia/reperfusion injury in mice. 2008 Hepatology pmid:18085707
Papaliodis D et al. The flavonoid luteolin inhibits niacin-induced flush. 2008 Br. J. Pharmacol. pmid:18223672
Lutzow YS et al. 15-Deoxy-Delta12,14-prostaglandin J2 induces chemokine expression, oxidative stress and microfilament reorganization in bovine mammary epithelial cells. 2008 J. Dairy Res. pmid:18226310
Torres D et al. Prostaglandin D2 inhibits the production of IFN-gamma by invariant NK T cells: consequences in the control of B16 melanoma. 2008 J. Immunol. pmid:18178816
Rajakariar R et al. Novel biphasic role for lymphocytes revealed during resolving inflammation. 2008 Blood pmid:18218853
Kuesap J et al. Prostaglandin D2 induces heme oxygenase-1 in human retinal pigment epithelial cells. 2008 Biochem. Biophys. Res. Commun. pmid:18174022
Oh JY et al. Accumulation of 15-deoxy-delta(12,14)-prostaglandin J2 adduct formation with Keap1 over time: effects on potency for intracellular antioxidant defence induction. 2008 Biochem. J. pmid:18237271
Austen KF Doing what I like. 2008 Annu. Rev. Immunol. pmid:17877459
Shefler I et al. Inhibition of basic secretagogue-induced signaling in mast cells by cell permeable G alpha i-derived peptides. 2008 Int. Arch. Allergy Immunol. pmid:17848806
Li W et al. Neuronal cyclooxygenase-2 activity and prostaglandins PGE2, PGD2, and PGF2 alpha exacerbate hypoxic neuronal injury in neuron-enriched primary culture. 2008 Neurochem. Res. pmid:17763946
Nomiya R et al. CRTH2 plays an essential role in the pathophysiology of Cry j 1-induced pollinosis in mice. 2008 J. Immunol. pmid:18390753
Liu Y et al. Increased expression of the peroxisome proliferator-activated receptor gamma in the immune system of weaned pigs after Escherichia coli lipopolysaccharide injection. 2008 Vet. Immunol. Immunopathol. pmid:18394717
Cao J et al. Characterization of prostanoid receptors present on adrenergic neurons innervating the porcine uterine longitudinal muscle. 2008 Prostaglandins Other Lipid Mediat. pmid:18403225
Zheng MS et al. Chemical constituents of Melandrium firmum Rohrbach and their anti-inflammatory activity. 2008 Arch. Pharm. Res. pmid:18409044
Churi SB et al. Intrathecal rosiglitazone acts at peroxisome proliferator-activated receptor-gamma to rapidly inhibit neuropathic pain in rats. 2008 J Pain pmid:18387855
Cekanova M et al. Gene alterations by peroxisome proliferator-activated receptor gamma agonists in human colorectal cancer cells. 2008 Int. J. Oncol. pmid:18360708
Moon TC et al. The effects of isoimperatorin isolated from Angelicae dahuricae on cyclooxygenase-2 and 5-lipoxygenase in mouse bone marrow-derived mast cells. 2008 Arch. Pharm. Res. pmid:18365692
Kimura H et al. A natural PPAR-gamma agonist, 15-deoxy-delta 12,14-prostaglandin J2, may act as an enhancer of PAI-1 in human proximal renal tubular cells under hypoxic and inflammatory conditions. 2008 Nephrol. Dial. Transplant. pmid:18367541
Paruchuri S et al. Leukotriene E4 activates peroxisome proliferator-activated receptor gamma and induces prostaglandin D2 generation by human mast cells. 2008 J. Biol. Chem. pmid:18411276
Papageorgiou E et al. Rosiglitazone attenuates insulin-like growth factor 1 receptor survival signaling in PC-3 cells. 2008 Jul-Aug Mol. Med. pmid:18475308
Pettipher R and Hansel TT Antagonists of the prostaglandin D2 receptor CRTH2. 2008 Jul-Aug Drug News Perspect. pmid:18836589
Takahashi N et al. Molecular characterization of TRPA1 channel activation by cysteine-reactive inflammatory mediators. 2008 Jul-Aug Channels (Austin) pmid:18769139
Tokuda H et al. Function of Rho-kinase in prostaglandin D2-induced interleukin-6 synthesis in osteoblasts. 2008 Jul-Aug Prostaglandins Leukot. Essent. Fatty Acids pmid:18771907
Kalogeromitros D et al. A quercetin containing supplement reduces niacin-induced flush in humans. 2008 Jul-Sep Int J Immunopathol Pharmacol pmid:18831918
Csányi G et al. Effects of 3-aminopyridine-induced seizures on platelet eicosanoid synthesis. 2008 May-Jun Pharmacol Rep pmid:18622059
Kase K et al. Inhibitory action of roxithromycin on histamine release and prostaglandin D2 production from beta-defensin 2-stimulated mast cells. 2009 Int. J. Mol. Med. pmid:19212651
Ricart KC et al. The permissive role of mitochondria in the induction of haem oxygenase-1 in endothelial cells. 2009 Biochem. J. pmid:19161347
O'Brien JJ et al. 15-deoxy-Delta12,14 prostaglandin J2-induced heme oxygenase-1 in megakaryocytes regulates thrombopoiesis. 2009 J. Thromb. Haemost. pmid:18983509
Kalantari P et al. 15-Deoxy-Delta12,14-prostaglandin J2 inhibits HIV-1 transactivating protein, Tat, through covalent modification. 2009 FASEB J. pmid:19299483
Mohri I et al. Inhibition of prostaglandin D synthase suppresses muscular necrosis. 2009 Am. J. Pathol. pmid:19359520
Moriai M et al. Down-regulation of hTERT expression plays an important role in 15-deoxy-Delta12,14-prostaglandin J2-induced apoptosis in cancer cells. 2009 Int. J. Oncol. pmid:19360348
Irikura D et al. Biochemical, functional, and pharmacological characterization of AT-56, an orally active and selective inhibitor of lipocalin-type prostaglandin D synthase. 2009 J. Biol. Chem. pmid:19131342
Johansson S et al. CC16 inhibits the migration of eosinophils towards the formyl peptide fMLF but not towards PGD2. 2009 Inflammation pmid:19132521
Kim DH et al. 15-Deoxy-Delta12,14-prostaglandin J2 upregulates the expression of heme oxygenase-1 and subsequently matrix metalloproteinase-1 in human breast cancer cells: possible roles of iron and ROS. 2009 Carcinogenesis pmid:19136476
Di Francesco L et al. Induction of prostacyclin by steady laminar shear stress suppresses tumor necrosis factor-alpha biosynthesis via heme oxygenase-1 in human endothelial cells. 2009 Circ. Res. pmid:19122175
Wang WM et al. PPAR-gamma agonists inhibit TGF-beta1-induced chemokine expression in human tubular epithelial cells. 2009 Acta Pharmacol. Sin. pmid:19098936
Niki E Lipid peroxidation: physiological levels and dual biological effects. 2009 Free Radic. Biol. Med. pmid:19500666
Suk FM et al. 15-deoxy-Delta(12,14)-prostaglandin J(2) inhibits fibrogenic response in human hepatoma cells. 2009 Toxicol. Lett. pmid:19429239
Kansanen E et al. Regulation of Nrf2-dependent gene expression by 15-deoxy-Delta12,14-prostaglandin J2. 2009 Free Radic. Biol. Med. pmid:19573595
Cocca C et al. 15-Deoxi-Delta(12,14)-prostaglandin J2 is a tubulin-binding agent that destabilizes microtubules and induces mitotic arrest. 2009 Biochem. Pharmacol. pmid:19576185
Thura M et al. GIF-0173 protects against cerebral infarction through DP1 receptor activation. 2009 Exp. Neurol. pmid:19576888
Lauring B et al. Laropiprant in combination with extended-release niacin does not alter urine 11-dehydrothromboxane B2, a marker of in vivo platelet function, in healthy, hypercholesterolemic, and diabetic subjects. 2009 J Clin Pharmacol pmid:19833861
Hironaka A et al. 15-Deoxy-Delta(12,14)-prostaglandin J(2) impairs the functions of histone acetyltransferases through their insolubilization in cells. 2009 Biochem. Biophys. Res. Commun. pmid:19799872